R&D Outsourcing Reaches Tipping Point As More Firms Do Most Trials Overseas
Executive Summary
Five years ago, Wyeth hit a roadblock in developing the intravenous antibiotic Tygacil (tigecyline) - not enough patients were enrolling in its Phase III trial
You may also be interested in...
Clinical Trial Modernization, Outsourcing Concerns Are Focus Of FDA/Duke Effort
In an FDA-Duke University Medical Center partnership to modernize the way clinical trials are conducted, close attention will be paid to the increase of outsourcing and off-shoring clinical trials
Clinical Trial Modernization, Outsourcing Concerns Are Focus Of FDA/Duke Effort
In an FDA-Duke University Medical Center partnership to modernize the way clinical trials are conducted, close attention will be paid to the increase of outsourcing and off-shoring clinical trials
India And China Not Yet Major Sites For FDA-Regulated Trials, Parexel Finds
While India now ranks among the top 10 countries conducting FDA-regulated clinical trials, it has yet to see a major influx of trial work